Funder
Hamilton Health Sciences Foundation
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference30 articles.
1. A Multicenter prospective clinical trial of (68)Gallium PSMA HBED-CC PET-CT restaging in biochemically relapsed prostate carcinoma: oligometastatic rate and distribution compared with standard imaging;McCarthy;Int J Radiat Oncol Biol Phys,2019
2. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls;Hofman;Radiographics,2018
3. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study;Hofman;Lancet,2020
4. Evaluation of 18F-DCFPyL PSMA PET/CT for prostate cancer: a meta-analysis;Pan;Front Oncol,2020
5. Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer;Szabo;Mol Imaging Biol,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献